BIMI International Medical (STU:63N) Cash-to-Debt : 0.22 (As of Sep. 2023)

View and export this data going back to . Start your Free Trial

What is BIMI International Medical Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. BIMI International Medical's cash to debt ratio for the quarter that ended in Sep. 2023 was 0.22.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, BIMI International Medical couldn't pay off its debt using the cash in hand for the quarter that ended in Sep. 2023.

The historical rank and industry rank for BIMI International Medical's Cash-to-Debt or its related term are showing as below:

STU:63N' s Cash-to-Debt Range Over the Past 10 Years
Min: 0 Med: 0.05 Max: 2.41
Current: 0.22

During the past 13 years, BIMI International Medical's highest Cash to Debt Ratio was 2.41. The lowest was 0.00. And the median was 0.05.

STU:63N's Cash-to-Debt is ranked worse than
69.13% of 664 companies
in the Healthcare Providers & Services industry
Industry Median: 0.69 vs STU:63N: 0.22

BIMI International Medical Cash-to-Debt Historical Data

The historical data trend for BIMI International Medical's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

BIMI International Medical Cash-to-Debt Chart

BIMI International Medical Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Cash-to-Debt

Get a 7-Day Free Trial

N/A

0.02

0.03

0.53

0.43

BIMI International Medical Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Cash-to-Debt	Get a 7-Day Free Trial															0.08	0.43	0.33	0.44	0.22

Competitive Comparison of BIMI International Medical's Cash-to-Debt

For the Pharmaceutical Retailers subindustry, BIMI International Medical's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BIMI International Medical's Cash-to-Debt Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, BIMI International Medical's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where BIMI International Medical's Cash-to-Debt falls into.

BIMI International Medical Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

BIMI International Medical's Cash to Debt Ratio for the fiscal year that ended in Dec. 2022 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	2.206	/	(2.422	+	2.728)
	=	0.43

BIMI International Medical's Cash to Debt Ratio for the quarter that ended in Sep. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	0.931	/	(1.873	+	2.315)
	=	0.22

BIMI International Medical (STU:63N) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

BIMI International Medical Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of BIMI International Medical's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

BIMI International Medical (STU:63N) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » BIMI International Medical Inc (STU:63N) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

BIMI:USA

Address

Chongqing Corporation Avenue, 9th Floor, Building 2, Yuzhong District, Chongqing, CHN, 400010

Website

https://www.usbimi.com

BIMI International Medical Inc is a healthcare product and provider, offering a broad range of healthcare products and related services and operates private hospitals in China. The company is engaged in four business segments, Pharmaceuticals wholesale, Medical devices wholesale, Medical services, and Pharmacy retail. It generates maximum revenue from the pharmaceuticals wholesale segment. It mainly sources its products from large state-owned pharmaceutical manufacturers and wholesalers and mid-sized or small private pharmaceutical manufacturers and wholesalers. The Company's revenues were generated in the PRC.

BIMI International Medical (STU:63N) Headlines

No Headlines